Carbon nanotubes for stabilization of nanostructured lipid particles by Gaunt, Nicholas P. et al.
Strathprints Institutional Repository
Gaunt, Nicholas P. and Patil-Sen, Yogita and Baker, Matthew J. and 
Kulkarni, Chandrashekhar V. (2015) Carbon nanotubes for stabilization 
of nanostructured lipid particles. Nanoscale, 7 (3). pp. 1090-1095. ISSN 
2040-3364 , http://dx.doi.org/10.1039/c4nr05593d
This version is available at http://strathprints.strath.ac.uk/51683/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
This is an Accepted Manuscript, which has been through the 
Royal Society of Chemistry peer review process and has been 
accepted for publication.
Accepted Manuscripts are published online shortly after 
acceptance, before technical editing, formatting and proof reading. 
Using this free service, authors can make their results available 
to the community, in citable form, before we publish the edited 
article. We will replace this Accepted Manuscript with the edited 
and formatted Advance Article as soon as it is available.
You can find more information about Accepted Manuscripts in the 
Information for Authors.
Please note that technical editing may introduce minor changes 
to the text and/or graphics, which may alter content. The journal’s 
standard Terms & Conditions and the Ethical guidelines still 
apply. In no event shall the Royal Society of Chemistry be held 
responsible for any errors or omissions in this Accepted Manuscript 
or any consequences arising from the use of any information it 
contains. 
Accepted Manuscript
Nanoscale
www.rsc.org/nanoscale
View Article Online
View Journal
This article can be cited before page numbers have been issued, to do this please use:  N. P. Gaunt, Y.
Patil-Sen, M. J. Baker and C. V. Kulkarni, Nanoscale, 2014, DOI: 10.1039/C4NR05593D.
Nanoscale RSC  
ARTICLE 
This journal is © The Royal Society of Chemistry 2014 Nanoscale, 2014, 00, 1-6 | 1  
P
Introduction 
Carbon nanotubes (CNTs), owing to their special properties 
such as small size and ability to bind with a broad range of 
molecules, are exploited in many biomedical and 
pharmaceutical applications1-5 such as drug delivery,6, 7 gene 
delivery,8 cancer therapy,6, 9 medical imaging10 and tissue 
engineering scaffolds.11 However, in vivo use of CNTs is still a 
task to be accomplished due to their debatable toxicity issues;8 
nevertheless some of the recent research in this direction is 
believed to be promising.1, 2, 12 Although CNTs are yet to be 
approved by FDA (Food and Drug Administration) for safe use 
in humans, their pre-clinical applications as biomaterials have 
been extremely effective.12 Many studies performed on animal 
models endorse CNTs being safe for living organisms provided 
that they are functionalized properly and more importantly, the 
method and site of use are appropriate.12 The functionalization 
is very important aspect in determining the biological toxicity 
of CNTs in almost all of the aforementioned applications, for 
which the CNT surface needs to be modified by non-covalent 
or covalent interactions using various molecules like e.g. lipids, 
proteins, surfactants, drugs, polymers, peptides, nucleic acids 
and metal nanoparticles. Some of these molecules not only 
interact but also self-organize on CNT surfaces.13, 14 
Amphiphilic molecules, like lipids, are among such molecules 
which form self-assembled nanostructures when in solvents.15 
However, with CNTs they self-organize in such a way that the 
non-polar part is shielded from polar medium via hydrophobic 
interactions with CNT surface while the hydrophilic part faces 
polar solvent medium, which is usually water based.10, 13, 16-20 
 The type of self-assembled nanostructure, also called liquid 
crystalline lipid phases interacting with carbon nanotubes could 
differ from lipid to lipid21 as well as with physicochemical 
conditions.22 Usually the lamellar nanostructure (Fig. 1) is most 
commonly observed which mimics plasma membrane whereas 
hexagonal and cubic types of nanostructures resemble complex 
intracellular biomembranes.15, 23 Lipid nanostructures are also 
used for many applications, for example, for separation of 
biomolecules,24 protein crystallization,25 synthesis of metal 
nanoparticles26 and electrophoresis gels for amphiphilic 
molecules.24 However, in some cases their applicability is 
hampered by their extremely high viscosity and inconsistent 
domain consistency. These problems are resolved by dispersing 
them into submicron (typical diameter 200-400 nm) or micron 
sized colloidal particles with large quantities of water (about 
80-95%).27, 28 The process involves kinetic stabilization of lipid 
nanostructures using some energy input and stabilizer 
molecules like surfactants, polymers, hydrocolloids or 
biomolecules resulting into oil-in-water (O/W) emulsions.28, 29 
1RWH +HUH µRLO¶ SKDVH UHIHUV WR OLSLG FKDLQV UHJLRQ 7KH 
original lipid self-assembly is usually preserved inside 
dispersed particles and the overall viscosity is reduced by a few 
orders of magnitudes thereby enhancing their applicability.29, 30 
Major application of internally self-assembled lipid particles is 
IRU µGUXJ GHOLYHU\¶ EHFDXVH RI WKH SRVVLELOLW\ RI ORDGLQJ WKHP
with hydrophilic, hydrophobic and amphiphilic molecules.31-33  
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Fig.1 CNT Stabilized Internally Self-assembled Lipid Particles. (A) In presence of water, amphiphilic lipid molecules self-assemble into various liquid crystalline phases 
such as lamellar and cubic nanostructures. (B) Highly viscous lipid phases like cubic nanostructures are kinetically stabilized (using ultrasound energy and CNT 
stabilizer) into fluid dispersion. Pristine single-walled (SW) and functionalized (-OH and  WCOOH) multi-walled (MW) CNTs were used to stabilize the oil-in-water 
(Pickering) emulsion.  
In this work we exploit CNTs as novel stabilizers for 
nanostructured lipid particles as depicted in Fig.1. Use of CNTs 
is expected to be significantly advantageous in stabilization of 
such systems because of their unique surface properties that 
facilitate extensive functionalization. Presence of lipid also 
overcame the destabilization of CNTs in aqueous solution 
which was otherwise occurring in minutes after their dispersion 
without lipid molecules. As mentioned earlier, CNTs 
themselves are promising candidates for drug delivery and 
other biomedical applications.12 Combining them with 
nanostructured lipid particles that could be also loaded with 
drugs may open up many new pathways for example, for 
combination therapy or polytherapy i.e. for delivering multiple 
drugs or a drug and other inhibitory molecules at the same time 
at the same target. Such therapies are required mainly against 
multidrug resisting macromolecules or pathogens.34, 35 The 
concentration of CNTs required to stabilize an emulsion (per 
unit volume of water) is extremely low (as low as 0.3 Pg/ml). 
Furthermore, the biocompatibility of CNTs is expected to be 
greatly enhanced due to decoration with lipid molecules. These 
features can be attributed to a very low to negligible in vivo 
toxicity of CNT stabilized lipid nanoparticles for biomedical 
and pharmaceutical applications. 
Results and Discussion 
Preparation of CNT-stabilized Nanostructured Lipid Particles  
Powdered forms of -COOH functionalized multi-walled (MW) 
CNTS, -OH functionalized MWCNTs and pristine single-
walled (SW) CNTs were pre-dispersed in water by probe 
ultrasonicator followed by addition of molten Dimodan U 
(DU). The DU is a commercial lipid mainly consisting of 
monoglycerides and it forms a bicontinuous cubic Pn3m phase 
(crystallographic space group 224) in excess water (at room 
temperature).36 The Pn3m phase exhibits 3-dimensionally 
folded curved bilayer draped over double diamond type 
mathematical minimal surface15 separating two continuous 
water networks (Fig. 1A) 7KH µELFRQWLQXRXV¶ IHDWXUH RI WKLV
nanostructure facilitates reconstitution and practically 
uninterrupted diffusion of amphiphilic molecules like 
membrane proteins providing them native like environment.37 
Each DU-CNT mixture in water was subjected to further 
ultrasonication in order to break large and inconsistent lipid 
domains formed during the hydration of a lipid. Dispersing the 
bulk lipid in this manner apparently speeds up the process of 
lipid hydration and thus equilibrium formation of self-
assembled nanostructures, which otherwise requires 
considerably long time (could be one or many days) and/or 
freeze-thaw cycling. While the bulk lipid phase breaks into 
particles, the lipid coated CNTs are presumed to form a shell 
around them (Fig. 1B). The interfacial stabilization avoids 
further aggregation of both, nanostructured lipid particles as 
well as CNTs. Such kinetic stabilization can be called a 
Pickering38 (due to the use of solid particles) emulsion of oil-in-
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ZDWHU 2: W\SH ZKHUH OLSLG IRUPV DQ µRLO SKDVH¶ ZKLOH
µH[FHVVZDWHU¶IRUPVDFRQWLQXRXVHPXOVLRQPHGLXP28 Such an 
aqueous medium and the hydrophobic lipid core of similar lipid 
particles (stabilized by surfactants) are shown to provide right 
environments for incorporation of hydrophilic and hydrophobic 
active pharmaceutical agents, respectively.32, 33 Moreover, the 
amphiphilic lipid bilayer fabricating the cubic nanostructure is 
useful for reconstitution of membrane proteins.39, 40 Dynamic 
light scattering studies confirmed that CNT stabilized 
nanostructured lipid particles were comparable in size (2-5 Pm) 
with those stabilized by conventional surfactant stabilizer-
pluronic F127 (Fig. 2).  
 
Fig.2 Particle size of nanostructured lipid particles (A) An average particle size of 
CNT stabilized nanostructured lipid particles was in the range of 2-5 Pm and it 
was comparable to the size of lipid particles stabilized by pluronic F127 
surfactant (B), as determined from dynamic light scattering experiments. An 
additional peak for surfactant based system could be attributed to surfactant 
micelles of about 100 nm size. 
Lipid Decoration on CNTs Revealed by Raman Spectroscopy  
Raman spectroscopy revealed CNT-lipid interactions 
responsible for their mutual stabilization in aqueous solutions 
(Fig. 3). The CNT spectra contain typical Raman graphite 
bands; the G band is assigned to the in-SODQHYLEUDWLRQRIµ&-C 
ERQG¶ WKH'EDQGQRW VKRZQ LVDFWLYDWHGE\ WKHSUHVHQFHRI
GLVRUGHU LQ FDUERQ V\VWHPV DQG WKH *¶ EDQG DWWULEXWHG WR WKH
overtone of the D band.41  Upon interaction and formation of 
&17VWDELOL]HGOLSLGSDUWLFOHVWKH*DQG*¶EDQGVGLVSOD\DEOXH 
shift (shift to higher wavenumbers). Table 1 lists the peak 
centers for characteristic bands from pure CNTs and 
nanostructured lipid particles containing CNTs.  A blue shift, in 
case of CNTs, is a result of either or a combination of the 
following: 1) the dispersion of CNTs, as opposed to a bundled 
state when pure41 2) coating of CNTs; Douroumis et al.42 have 
shown significant blue shifts when analysing lipid coated 
SWCNTs and suggest that the presence of functionality affects 
the symmetric radial vibrations of the hollow cylinders through 
stiffening which are attributed to the interactions between the 
CNTs and the lipid molecules 3) subjecting CNTs to a high 
pressure.43   
 Significant blue shifts (Table 1) observed in all spectra of 
lipid nanoparticles containing CNTs provide an evidence for 
µGLVSHUVHG¶ UDWKHU WKDQ µEXQGOHG¶ &17V +\GURSKRELF
interactions between CNT surface and alkyl chains of lipid 
molecules further contribute to the blue shift. Moreover, CNTs 
are exerted with a greater pressure due to increase in the overall 
viscosity of lipid particles because of dehydration. Decrease in 
relative intensities of typical CNT bands (as compared to 
uncoated CNTs) and emergence of prominent lipid signals also 
prove the fact that CNTs were decorated with lipid molecules.  
 
Fig 3 Raman spectra elucidating lipid decoration on CNTs Raman spectra of (A) 
pure lipid, MWCNT-COOH and CNT stabilized lipid nanoparticles containing 5.0 
ʅŐ ?ŵů DtEd-COOH, (B) pure lipid, -OH functionalized multi-walled carbon 
nanotubes (MWCNT-K, ?ĂŶĚ ůŝƉŝĚŶĂŶŽƉĂƌƚŝĐůĞƐ ĐŽŶƚĂŝŶŝŶŐ  ? ? ?ʅŐ ?ŵůDtEd-
OH, and (C) pure lipid, single-walled carbon nanotubes (SWNT) and lipid 
ŶĂŶŽƉĂƌƚŝĐůĞƐ ĐŽŶƚĂŝŶŝŶŐ  ? ? ? ? ? ? ʅŐ ?ŵů ^tEd  ?KƚŚĞƌĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ? ZĂŵĂŶ
spectra are shown in ESI Fig. S1). All curves represent an average of ten spectra 
where intensities, in arbitrary units (labels not shown) are plotted along y-axis. 
ůƵĞ ƐŚŝĨƚ ŝŶ ƚǇƉŝĐĂů 'ĂŶĚ ' ?ďĂŶĚƐ ŽĨEdƐ ƌĞƉƌĞƐĞŶƚ ƚŚĞ ŝŶƚĞƌĂĐƚŝŽŶďĞƚǁĞĞŶ
CNT surface and lipid molecules. Lipid decoration over CNTs was also depicted by 
decrease in relative intensities of CNT peaks and appearance of lipid signals 
ǁŚŝĐŚĂƌĞǀŝƐŝďůĞ ĨƌŽŵďůƵĞĐƵƌǀĞƐ ?ĂƐŚĞĚ  ?'ďĂŶĚ ?ĂŶĚĚŽƚƚĞĚ  ?' ?ďĂŶĚ ? ůŝŶĞƐ
are used to guide the eyes. (D) Schematic diagram of lipid self-assembling on 
CNT surface. Alkyl chains of lipid molecules interact with hydrophobic CNT 
surface whereas the hydrophilic lipid headgroups face aqueous region. Interior 
of particles is filled with self-assembled lipid nanostructure as indicated by the 
cross section of lipid particle (yellow). 
 
Table 1 Raman wavenumbers and shift for CNTs and nanostructured lipid particles with 
CNTs. 
Optimum CNT:Lipid Ratio and Stability of Nanostructured 
Lipid Particles 
As discussed earlier, interface of lipid particles is stabilized by 
a layer of CNTs enclosing self-assembled nanostructures at the 
core. However, we observed that there is a particular range of 
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CNT:lipid ratio in which they result in stable emulsions; ratios 
higher than this cause aggregation of CNTs as shown in Fig. 4 
(arrows indicate visible aggregates of excess CNTs). Similarly 
lower ratios do not lead to stable emulsions because of an 
insufficient number of CNTs in the solution. Best working 
concentrations for MWCNT-COOH and MWCNT-OH were 
found to be between 3 to 5 Pg/ml whereas for SWCNT they 
were in the range of 0.3-0.45 Pg/ml. Previous research on the 
toxicity of pristine MWCNTs demonstrates that 40 Pg/ml 
dosage should have no toxicity on human T lymphocytes,44 
while the research on pristine SWCNTs states that 7.5 Pg/ml 
dosage causes only 10% decrease in cell proliferation and  
 
Fig. 4 Optimum CNT concentrations for stable emulsions Stable emulsions 
(shown by purple shade) were obtained in the region of 3.0-5.0 Pg/ml for 
MWCNT WOH as in (A) and MWCNT WCOOH as in (B). The concentration of 
SWCNTs for stable emulsions as in (C) was about an order of magnitude less than 
above numbers. It was also possible to get stable emulsions at concentrations 
very near to these ranges (as indicated by color gradient). For lower 
concentrations of CNTs, large domains of lipid were seen as there were too little 
CNTs per lipid whereas for higher concentrations there were too many CNTs 
which tend to aggregate; some of these are indicated by black arrows.  
activity in Mesothelioma cell line MSTO-211H.45 CNT 
concentrations employed for stabilizing nanostructured lipid 
particles, in this work are well below (by an order of 
magnitude) these toxicity limits. Moreover, the 
functionalization (in case of MWCNTs) and coating with lipid 
molecules are expected to enhance biocompatibility and reduce 
the likelihood of a toxic effect.  
 
Fig. 5 Stability and regeneration of lipid particulate emulsions (A) Concentration 
of dispersed phase, mainly lipid could be tuned from 2 % to 20 %. At 20 % the 
emulsions become thick due to higher lipid material above which it was hard to 
prepare them using the ultrasonication method. (B) CNT stabilized 
nanoparticulate emulsions were stable for about 2 months, after which a few 
CNT aggregates were observed. It was, however possible to re-disperse them 
merely upon gentle shaking. (C) Emulsions could be completely dehydrated and 
dispersed again. There was a little foam on the top of re-dispersed emulsion 
which settled in about 2 days resulting into the stable emulsion. Above studies 
correspondingly demonstrate interesting properties of CNT stabilized emulsions 
as, capability of uptaking higher quantities of functional material (e.g. active 
molecules like drugs), shelf-life and practicability of storage/transport.  
We were able to stabilize as low as 2 % dispersed phase 
emulsions using the same lipid:CNTs ratio (Fig. 5A) used for 
preparing all above emulsions (5 % dispersed phase). To 
another end, emulsions up to 20 % lipid material were also 
prepared by maintaining CNT:lipid ratio constant (Fig. 5A). 
This wide range of nanostructured lipid particle concentrations 
facilitates their loading with extensively varied quantities of 
drug molecules. CNT stabilized emulsions were stable for 
about 2 months after which CNTs start aggregating, but they 
were well dispersed again with only gentle shaking (Fig. 5B). 
Emulsions were also capable of retaining their stability after 
complete dehydration via freeze-drying followed by 
rehydration (Fig. 5C). The dehydrated lipid nanoparticles 
exhibited lamellar nanostructure similar to the dry lipid at 
ambient temperatures (see small angles x-ray scattering patterns 
in ESI Fig. S2).    
Experimental  
Materials 
Single-walled carbon nanotubes (SWCNT) and multi-walled 
carbon nanotubes with -OH functionalization (MWCNT-OH) 
were obtained from Nanoamor (Houston, USA) whereas ±
COOH functionalized multi-walled CNTs (MWCNT-COOH) 
were purchased from Sigma-Aldrich (Athens, Greece). The 
lipid, Dimodan U/J (DU) was a generous gift from Danisco 
(Brabrand, Denmark). DU is a low-cost commercial product, as 
compared to its pure lipid analogues, containing more than 98% 
mono-glycerides. The triblock copolymer pluronic F127 
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(PEO99-PPO67-PEO99) was purchased from Sigma-Aldrich, UK. 
All solutions were prepared with Millipore water.  
Preparation of Nanostructured Lipid Particles 
First, powdered CNTs (MWCNT-OH, MWCNT-COOH and 
SWCNT) were dispersed in 100 ml water using probe 
ultrasonicator (ULT065 from Ultrawave, Cardiff, UK) at 40% 
power for 2 minutes without pulse. CNTs were stable on their 
own (without lipid) during preparation time (for about 20 
minutes). The solution of surfactant F127 was prepared by 
simply stirring 200 mg of surfactant in 100 ml water. 9.5 ml of 
each of above solutions was then added to 500 mg of molten 
DU in a glass vial. The mixtures were then subjected to 
ultrasonication with same parameters as CNT dispersions. 
Emulsions were allowed to cool down (about 10 minutes) prior 
to further use. 
Particle Size Measurement Using Dynamic Light Scattering 
Particle sizes in dispersions were determined by using the 
Zetasizer Nano-ZS dynamic light scattering (DLS) equipment 
(from Malvern Instruments, UK). The data, in the form of 
particle size distribution was analyzed using Malvern DTS 
version 5.0. Each sample was tested 10 times and 5 such 
repeats were performed to get final plots. 
Raman Spectroscopy on Lipid-CNT Samples 
CNT, lipid and CNT-lipid samples were dehydrated using 
nitrogen gas followed by vacuum drying in the desiccator for 
about 20 minutes. Spectroscopic measurements were carried 
out on a Horiba Jobin-Yvon LabRAM HR800 spectrometer. A 
532 nm laser was utilized to collect spectra from 100 ± 4000 
cm-1 using a grating of 600 g mm-1 and blazed at 750 nm. 
Spectra were acquired using x50 long working distance 
objective with a numerical aperture of 0.50. The confocal hole 
ZDV VHW DW  ȝP IRU VSHFWUDO FROOHFWLRQV 7KH GHWHFWRU XVHG
was an Andor electromagnet (EM) charged coupled device 
(CCD). A video camera with the Raman system was used to 
guide spectral collection. All spectra were collected with 
sample situation on Calcium Fluoride slides (Crystran, UK). 
The instrumentation was calibrated before operation to silicon 
at the spectral line of 520.8 cm-1. Spectra were acquired using 
the 532 nm laser at 1 % exposure for 10 seconds and 
accumulated 5 times. Immediate data interrogation and 
manipulation was carried out on the raw data using the LabSpec 
6 spectroscopy software suite (HORIBA Scientific).  
Conclusions and Perspectives 
To conclude, we were able to produce nanostructured lipid 
particles with internal self-assembly using various CNTs as 
emulsion stabilizers. In the past, there have been several studies 
on using lipids or surfactants for dispersion and 
functionalization of CNTs, however this is the first report 
showing a range of CNTs for stabilization of lipid based 
emulsions. Requirement of very low levels of CNTs is 
promising for in vivo applications as the amount of CNTs 
administered into the body is an order of magnitude below 
toxicity limits revealed by the current literature, in addition, the 
biocompatibility of CNTs is greatly improved due to their 
coating with lipid molecules. Furthermore, owing to the 
possibility of loading functional molecules within lipid self-
assembly as well as on CNT surface, the CNT stabilized lipid 
particles exhibit an enormous potential in emerging areas of 
pharmaceutical and biomedical sciences with special relevance 
to the development of combination therapies against major 
diseases. Fundamental properties of these emulsions are that 
they exhibit good kinetic stability; moreover, they can be 
regenerated after total dehydration of constituents. This allows 
for easy storage and transport of stabilized emulsions for use in 
harsh environments such as developing countries or forward 
based military hospitals.   
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